177 related articles for article (PubMed ID: 38066590)
21. Integrated screening and treatment services for HIV, hypertension and diabetes in Kenya: assessing the epidemiological impact and cost-effectiveness from a national and regional perspective.
Kasaie P; Weir B; Schnure M; Dun C; Pennington J; Teng Y; Wamai R; Mutai K; Dowdy D; Beyrer C
J Int AIDS Soc; 2020 Jun; 23 Suppl 1(Suppl 1):e25499. PubMed ID: 32562353
[TBL] [Abstract][Full Text] [Related]
22. Ambient particulate matter burden of disease in the Kingdom of Saudi Arabia.
Rojas-Rueda D; Alsufyani W; Herbst C; AlBalawi S; Alsukait R; Alomran M
Environ Res; 2021 Jun; 197():111036. PubMed ID: 33775683
[TBL] [Abstract][Full Text] [Related]
23. Obesity Burden and Impact of Weight Loss in Saudi Arabia: A Modelling Study.
Alqahtani SA; Al-Omar HA; Alshehri A; Abanumay A; Alabdulkarim H; Alrumaih A; Eldin MS; Schnecke V
Adv Ther; 2023 Mar; 40(3):1114-1128. PubMed ID: 36633732
[TBL] [Abstract][Full Text] [Related]
24. Socioeconomic determinants and inequalities in the prevalence of non-communicable diseases in Saudi Arabia.
Al-Hanawi MK
Int J Equity Health; 2021 Jul; 20(1):174. PubMed ID: 34321000
[TBL] [Abstract][Full Text] [Related]
25. A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia.
Sanai FM; Alghamdi M; Dugan E; Alalwan A; Al-Hamoudi W; Abaalkhail F; AlMasri N; Razavi-Shearer D; Razavi H; Schmelzer J; Alfaleh FZ
J Infect Public Health; 2020 Nov; 13(11):1715-1723. PubMed ID: 32988769
[TBL] [Abstract][Full Text] [Related]
26. Financial risk protection against noncommunicable diseases: trends and patterns in Bangladesh.
Rahman T; Gasbarro D; Alam K
BMC Public Health; 2022 Sep; 22(1):1835. PubMed ID: 36175951
[TBL] [Abstract][Full Text] [Related]
27. The global impact of non-communicable diseases on healthcare spending and national income: a systematic review.
Muka T; Imo D; Jaspers L; Colpani V; Chaker L; van der Lee SJ; Mendis S; Chowdhury R; Bramer WM; Falla A; Pazoki R; Franco OH
Eur J Epidemiol; 2015 Apr; 30(4):251-77. PubMed ID: 25595318
[TBL] [Abstract][Full Text] [Related]
28. The case for investing in the prevention and control of non-communicable diseases in the six countries of the Gulf Cooperation Council: an economic evaluation.
Elmusharaf K; Grafton D; Jung JS; Roberts E; Al-Farsi Y; Al Nooh AA; Bin Belaila B; ElShamy A; Al-Zuabi H; Al Mutawa KA; Alraisi S; Al Lawat N; Gharbal A; Alomary S; Kulikov A; Pourghazian N; Slama S; Tarlton D; Banatvala N
BMJ Glob Health; 2022 Jun; 7(6):. PubMed ID: 35649631
[TBL] [Abstract][Full Text] [Related]
29. How Could Different Obesity Scenarios Alter the Burden of Type 2 Diabetes and Liver Disease in Saudi Arabia?
Coker T; Saxton J; Retat L; Guzek J; Card-Gowers J; BinDhim NF; Althumiri NA; Aldubayan K; Razack HIA; Webber L; Alqahtani SA
Obes Facts; 2023; 16(6):559-566. PubMed ID: 37552973
[TBL] [Abstract][Full Text] [Related]
30. Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.
Yadav S; Delau O; Bonner AJ; Markovic D; Patterson W; Ottey S; Buyalos RP; Azziz R
Elife; 2023 Aug; 12():. PubMed ID: 37534878
[TBL] [Abstract][Full Text] [Related]
31. Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal Study.
AlHarbi M; Othman A; Nahari AA; Al-Jedai AH; Cuadras D; Almalky F; AlAzmi F; Almudaiheem HY; AlShubrumi H; AlSwat H; AlSahafi H; Sindi K; Basaikh K; AlQahtani M; Lamotte M; Yahia M; Hassan ME; AlMutlaq M; AlRoaly M; AlZelaye S; AlGhamdi Z
Adv Ther; 2024 Mar; 41(3):1120-1150. PubMed ID: 38240948
[TBL] [Abstract][Full Text] [Related]
32. Cost-of-illness analysis of type 2 diabetes mellitus in Iran.
Javanbakht M; Baradaran HR; Mashayekhi A; Haghdoost AA; Khamseh ME; Kharazmi E; Sadeghi A
PLoS One; 2011; 6(10):e26864. PubMed ID: 22066013
[TBL] [Abstract][Full Text] [Related]
33. The risk, burden, and management of non-communicable diseases in cerebral palsy: a scoping review.
Ryan JM; Allen E; Gormley J; Hurvitz EA; Peterson MD
Dev Med Child Neurol; 2018 Aug; 60(8):753-764. PubMed ID: 29572812
[TBL] [Abstract][Full Text] [Related]
34. The global impact of non-communicable diseases on macro-economic productivity: a systematic review.
Chaker L; Falla A; van der Lee SJ; Muka T; Imo D; Jaspers L; Colpani V; Mendis S; Chowdhury R; Bramer WM; Pazoki R; Franco OH
Eur J Epidemiol; 2015 May; 30(5):357-95. PubMed ID: 25837965
[TBL] [Abstract][Full Text] [Related]
35. The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.
Aggarwal A; Patel P; Lewison G; Ekzayez A; Coutts A; Fouad FM; Shamieh O; Giacaman R; Kutluk T; Khalek RA; Lawler M; Boyle P; Sarfati D; Sullivan R
PLoS One; 2020; 15(4):e0232077. PubMed ID: 32339197
[TBL] [Abstract][Full Text] [Related]
36. The health and economic impact and cost effectiveness of interventions for the prevention and control of overweight and obesity in Kenya: a stakeholder engaged modelling study.
Wanjau MN; Kivuti-Bitok LW; Aminde LN; Veerman JL
Cost Eff Resour Alloc; 2023 Sep; 21(1):69. PubMed ID: 37735408
[TBL] [Abstract][Full Text] [Related]
37. The estimated cost of dementia in Japan, the most aged society in the world.
Sado M; Ninomiya A; Shikimoto R; Ikeda B; Baba T; Yoshimura K; Mimura M
PLoS One; 2018; 13(11):e0206508. PubMed ID: 30418983
[TBL] [Abstract][Full Text] [Related]
38. Budget impact of introducing oral semaglutide to the public healthcare benefit package in Saudi Arabia.
Alluhidan M; Alabdulkarim H; Alrumaih A; Al-Turaiki A; Alshahrani A; Al-Qahtani S; Alhossan A; Al-Jedai A
J Med Econ; 2023; 26(1):1455-1468. PubMed ID: 37933169
[TBL] [Abstract][Full Text] [Related]
39. Cost of disorders of the brain in Europe 2010.
Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
[TBL] [Abstract][Full Text] [Related]
40. The impact of seven major noncommunicable diseases on direct medical costs, absenteeism, and presenteeism in Gulf Cooperation Council countries.
Finkelstein EA; Malkin JD; Baid D; Alqunaibet A; Mahdi K; Al-Thani MBH; Abdulla Bin Belaila B; Al Nawakhtha E; Alqahtani S; El-Saharty S; Herbst CH
J Med Econ; 2021; 24(1):828-834. PubMed ID: 34138664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
